Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 31 Jul 2018 |
2 | Reply to Exam Report (MIS-R) | 20 Sep 2018 |
3 | Journal Copy | 06 Nov 2019 |
4 | TM-O(NOTICE OF OPPOSITION) | 01 Jan 2020 |
5 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 14 Feb 2024 |
1 | Hearing Notice (Show Cause) | 8592331 | 4284808 | 15 Jul 2019 |
2 | Tribunal Accepted Notice for : 3903555 | 8823140 | 4347738 | 26 Aug 2019 |
3 | Opposition Notice | 9527928 | 4685873 | 06 Jan 2020 |
4 | Opposition Counter Statement | 10070082 | 4905229 | 15 Jun 2020 |
5 | Hearing Notice | 17222897 | 6492445 | 25 Jan 2024 |
Trademark was applied on 31 July 2018 with IP India.
Proprietor of Ejalong is EMCURE PHARMACEUTICALS.
Class(es) in which the trademark was applied to is 5.
Status of Ejalong is Opposed.
Application number alloted to the trademark is 3903555.
Aditya & Associates is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD